Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-11-04 Metzger Michael A President and COO Sale −100,000 $20.31 $2.0M 17,659
2020-11-04 Metzger Michael A President and COO Option exercise · Stock Options (Right to buy) −100,000 0
2020-07-31 Meyers Michael L. SVP, Chief Medical Officer Other acquisition +2,665 $7.97 $21K 13,395
2020-07-06 Meyers Michael L. SVP, Chief Medical Officer Grant or award +3,500 10,730
2020-02-12 Metzger Michael A President and COO Grant or award +15,000 17,659
2020-02-12 Metzger Michael A President and COO Grant or award · Stock Option (Right to Buy) +140,000 140,000
2020-02-12 Shea Richard P Chief Financial Officer Grant or award · Stock Option (Right to Buy) +43,200 43,200
2020-02-12 Meyers Michael L. SVP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +50,825 50,825
2020-02-12 Morrison Briggs Chief Executive Officer Grant or award · Stock Option (Right to Buy) +194,000 194,000
2020-02-12 Ordentlich Peter Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2020-02-12 Egros Fabrice Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2020-02-12 Jarrett Jennifer Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2020-02-12 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2020-02-12 Legault Pierre Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2020-02-12 Meury William Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2020-02-12 Podlesak Dennis Director Grant or award · Stock Option (Right to Buy) +44,000 44,000
2020-02-04 Morrison Briggs Chief Executive Officer Purchase +12,500 $8.00 $100K 43,900
2020-01-31 Shea Richard P Chief Financial Officer Other acquisition +1,505 $7.97 $12K 7,121
2019-10-10 Morrison Briggs Chief Executive Officer Purchase +11,000 $5.40 $59K 31,400
2019-07-31 Shea Richard P Chief Financial Officer Other acquisition +1,401 $4.89 $7K 5,616

Page 22 of 25 · 500 trades